Waldenstrom Macroglobulinemia Latest Advances
Find the Latest Research About Waldenstrom Macroglobulinemia
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6615 publications
Ring of fire cells: plasma cell-predominant relapse of Waldenström macroglobulinemia.
Journal: Blood
Published: April 09, 2026
Refining prognostic tools in Waldenström macroglobulinemia.
Journal: Blood advances
Published: March 31, 2026
Bruton protein-tyrosine kinase (BTK) FDA-approved small molecule inhibitors used for the management of neoplastic and inflammatory disorders.
Journal: Pharmacological research
Published: March 31, 2026
IgG-κ lymphoplasmacytic lymphoma complicated by bilateral femoral neck fractures secondary to bone involvement
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 29, 2026
Masquerading as an Interstitial Lung Disease: Intravascular Large B-Cell Lymphoma With Prominent Neo-Angiogenesis.
Journal: International journal of surgical pathology
Published: March 23, 2026
Post-marketing surveillance of tirabrutinib for Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma in Japan.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: March 15, 2026
The Challenges Associated with the Diagnosis and Treatment for Aplastic Anemia Concurrent with Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
Severe aplastic anemia concurrent with lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: A case report.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.
Journal: Annals of medicine
Published: March 09, 2026
Last Updated: 04/28/2026